The Israel National Hemophilia Center is a tertiary multidisciplinary comprehensive referral center for evaluation, diagnosis and treatment of patients with Hemophilia and other bleeding disorders.

The center provides many innovative out patient clinic services. Most Hemophilia patients in Israel are trained to perform home treatment but need assistance occasionally. Our specialized team of hematologists and nurses, trained in the field of coagulation and Hemophilia, provide the evaluation, treatment, and follow up for bleeding episodes.

Our pediatric coagulation services provide diagnosis, treatment and consultation for children with Hemophilia and other bleeding disorders as well as for pediatric patients who experience Ischemic Stroke, Arterial or Venous Thrombosis, we provide anticoagulant treatment and long-term follow-up for children with Thrombophilia.

We provide an array of unique activities for children with Hemophilia from summer camps to special sports training programs.

Carried out in cooperation with the laboratories of the Institute of Thrombosis and Hemostasis, we provide prenatal/carrier detection for other congenital bleeding disorders.

We provide 24-hour emergency consultation services for both patients and medical staff in Israel including a mobile "Rescue Team.".

Our Orthopedic Clinic provides conservative treatment, radioactive, arthroscopic and surgical synovectomies, joint replacement (including multiple joints in a single session) and rehabilitation, including Physiotherapy, Hydrotherapy and sport groups.

Our hepatologist and infectious diseases specialists provide follow up and treatment for Hemophilia patients infected with HIV and HCV.

We also offer a dental clinic and counseling services.

Our Center is also a leader in training. We serve as the World Federation of Hemophilia's (WFH) [www.WFH.org] international training center for Hemophilia caregivers from developing countries. We provide "wet" surgical workshops to teach improved techniques for hemorrhage control for developing countries, including performance of complex orthopedic surgery by the local team, under the supervision of our expert orthopedic surgeon, hematologist, and lab officer. Many of these improved techniques were developed in our Center and are now standards of the WFH with the support and cooperation of the Ministries of Health and Foreign Affairs.

The Israel National Hemophilia Center developed Fibrin glue, now used routinely in all surgical procedures to reduce the risk of re-bleeding.

Director - Prof. Uri Martinowitz Prof. Martinowitz received his medical degree from the Sackler School of Medicine, Tel Aviv University,Israel.He specialized in Hematology/Oncology at the Sheba Medical Center, and was trained also at the Royal Free and King’s College Haemophilia Centers in the United Kingdom in the field of Hemophilia and coagulation.   In 1980 Prof. Martinowitz established the Hemophilia Center at the Chaim Sheba Medical Center, started as a one-man operation and expanded to a national comprehensive Hemophilia center with multidisciplinary team [of adult and pediatric hematologists, orthopedic surgeons, AIDS and Hepatitis specialists, dental surgeons, genetic counselor, psychologist, social worker, nurses and technicians] providing care to all patients in the country with Hemophilia and severe coagulopathies. The center gained national and international recognition and since 1993, it has been an international training center of the World Federation of Hemophilia (WFH).   Prof. Martinowitz is past president and chairman of the Israeli Hemophilia Association, was an executive member of the World Federation of Hemophilia, the president and chairman of the 1998 WFH congress, the initiator of the WFH surgical training program. He traveled numerous times to developing countries to teach, organize workshops, train hematologists, technicians, surgeons and other medical professionals and participate in operations of Hemophilia patients in these countries. He is the recipient of the Award of the Chairman of the Parliament (Knesset), the Exemplary Physician’s Award of the Society of Law and Medicine, the 1994 WFH award of best tweening program of the year.   Prof. Martinowitz developed treatment modalities that improved the safety and reduced the cost of treatment of patients with bleeding disorders, e.g., the adjusted-dose continuous infusion of coagulation products, special fibrin glue formulation and recently, he introduced the use of recombinant factor VIIa for the treatment of exsanguinating Trauma victims.   Prof. Martinowitz is Advisor to the Israeli Defense Forces (IDF) in the field of hemorrhage control and a member of the Hemorrhage Control Steering Research Committee of the U.S. Army Medical Research and Materiel Command’s, Combat Casualty Care (CCC) Research Program.